Prevention for those who can pay: Insurance reimbursement of genetic-based preventive interventions in the liminal state between health and disease

Journal of Law and the Biosciences

Volumn 2, Issue 3, 2016, Pages 365-395

  Prince, Anya E R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

ACA; ACMG; Health disparity; Insurance coverage; Predictive genetic testing; Prevention

Indexed keywords

EID: 85006151385     PISSN: None     EISSN: 20539711     Source Type: Journal    
DOI: 10.1093/jlb/lsv008     Document Type: Article

References (76)

1. Carla Denly, U.S. Ranks near Bottom among Industrialized Nations in Efficiency of Health Care Spending, UCLA NEWSROOM, Dec. 12, 2013, http://newsroom.ucla.edu/portal/ucla/weak-u-s-health-care-systemranks-249652.aspx (accessedMarch 3, 2015)
2. Abdulrahman El-Sayed, Prevention vs. Treatment and the Perverse Incentives Inflating the Costs of Healthcare, HUFFINGTON POST, Oct. 18, 2011, http://www.huffingtonpost.com/abdulrahman-m-elsayed/ health-care-prevention-b-1015734.html (accessedMarch 3, 2015)
3. Genetics and Public Policy Center, Genetic Testing Practice Guidelines: Translating Genetic Discoveries into Clinical Care, 27, 2008, http://www.dnapolicy.org/images/issuebriefpdfs/ Professional-Guidelines-Issue-Brief.pdf (accessed March 3, 2015)
4. Patricia J. Zettler et al., 23andMe, the Food and Drug Administration, and the Future of Genetic Testing, 174 JAMA INT. MED. 493, 493 (2014)
5. Robert S. Gordon, Jr., An Operational Classification ofDisease Prevention, 98PUB.HEALTHREP. 107, 107 (1983)
6. H. GILBERTWELCH et al., OVERDIAGNOSED: MAKING PEOPLE SICK IN THE PURSUIT OF HEALTH (2011)
7. Anya E.R. Prince & Benjamin E. Berkman, When Does an Illness Begin:Genetic Discrimination and DiseaseManifestation, 40 J.L. MED. & ETHICS 655, 662 (2012)
8. Anthony J. Viera, Predisease:When Does ItMake Sense?, 33 EPIDEMIOLOGIC REV. 122 (2011)
9. Teri. A.Manolio et al., Implementing GenomicMedicine in the Clinic:The Future Is Here, 15 GENET. MED. 258, 262 (2013)
10. Muin. J. Khoury et al., The Evidence Dilemma in GenomicMedicine, 27HEALTH AFF. 1600, 1604-05 (2008)
11. Wylie Burke, 60 Clinical Validity and Clinical Utility of Genetic Tests, CURR. PROTOCOLS HUM. GENET. 9:15.1, 9:15.3 (2009)
12. U.S. Department of Health and Human Services, Secretary's Advisory Committee on Genetics, Health, and Society (SACGHS), Coverage and Reimbursement of Genetic Tests and Services (2006), http://osp.od.nih.gov/sites/default/files/CR-report.pdf (accessed March 3, 2015)
13. Michael D. Graf et al., Genetic Testing Insurance Coverage Trends: A Review of Publicly Available Policies from the LargestUS Payers, 10 PERSONALIZEDMED. 235, 235 (2013)
14. Michael J. DeBoer, Medicare Coverage Policy and Decision Making, Preventive Services, and Comparative Effectiveness Research before and after the Affordable Care Act, 7 J.HEALTH & BIOMED. L. 493, 504-05 (2011)
15. Cynthia E. Boyd, Medicare: It's Time to Talk About Changing It, 19ANNALSHEALTHL. 79, 82 (2009)
16. Facing Our Risk of Cancer Empowered (FORCE), Insurance, Financial Assistance, Cost of Services, http://www.facingourrisk.org/info-research/finding-health-care/financial-help/ (accessedMarch 2, 2015)
17. National Human Genome Research Instiute (NHGRI), Reimbursement Models to Promote Evidence Generation and Innovation for Genomic Tests. Workshop Summary (2012), http://www.genome.gov/27552210 (accessedMarch 3, 2015)
18. James P. Evans, Health Care in the Age of GeneticMedicine, 298 J. AM. MED. ASS'N 2670, 2671 (2007)
19. Marc S. Williams, Can Genomics Deliver on the Promise of Improved Outcomes and Reduced Costs, 11 DISEASEMGMT. HEALTH OUTCOMES 277, 281-82 (2003)
20. Megan Latchaw et al., Health Insurance Coverage of Genetic Services in Illinois, 12 GENET. MED. 525 (2010)
21. Wolf H. Rogowski et al., Criteria for Fairly Allocating Scarce Health-Care Resources to Genetic Tests: Which MatterMost?, 22 EUR. J. HUM. GENET. 25, 27 (2013)
22. Arwen H. Pieterse et al., Longer-Term Influence of Breast Cancer Genetic Counseling on Cognitions and Distress: Smaller Benefits for Affected Versus Unaffected Women, 85 PATIENT EDUC. & COUNSELING 425, 430 (2011)
23. Chris M.R. Smerecnik et al., A Systematic Review of the Impact of Genetic Counseling on Risk Perception Accuracy, 18 J. GENET. COUNSELING 217 (2009)
24. Tabitha A. Harrison et al., Billing forMedical Genetics andGenetic Counseling Services:ANational Survey, 19 J. GENET. COUNSELING 38, 40 (2010)
25. Mark A. Rothstein & Sharona Hoffman, Genetic Testing, Genetic Medicine, and Managed Care, 34WAKE FOREST L. REV. 849, 876 (1999)
26. Alexandra K. Glazier, Genetic Predispositions, Prophylactic Treatments and Private Health Insurance: Nothing Is Better Than a Good Pair of Genes, 23 AM. J.L.&MED. 45, 48 (1997)
27. National Heart, Lung, and Blood Institute, How Is Hemochromatosis Diagnosed?, http://www. nhlbi.nih.gov/health/health-topics/topics/hemo/diagnosis (accessed March 3, 2015)
28. Mayo Clinic Hemochromatosis: Tests & Diagnosis, http://www.mayoclinic.org/diseases-conditions/hemochromatosis/ basics/tests-diagnosis/con-20023606 (accessedMarch 3, 2015)
29. MaryBeth Musumeci, A Guide to the Medicaid Appeals Process, KAISER FAMILY FOUNDATION, 2012, http://www.scdd.ca.gov/res/docs/pdf/Whats-New/KaiserGuidetoMedicaidAppealsProcess.pdf (accessedMarch 3, 2015)
30. National HumanGenome Research Institute (NHGRI), Questions About the BRCA1 and BRCA2 Gene Study and Breast Cancer (2012), https://www.genome.gov/10000940 (accessedMarch 3, 2015)
31. USPSTF, http://www.uspreventiveservicestaskforce.org/about.htm (accessedMarch 3, 2015)
32. Grace Wang et al., Eligibility Criteria in Private and Public Coverage Policies for BRCA Genetic Testing and Genetic Counseling, 13GENET. MED. 1045, 1046-47 (2011)
33. Dawn C. Allain et al., Consumer Awareness and Attitudes About Insurance Discrimination Post Enactment of the Genetic Information Nondiscrimination Act, 11 FAMILIAL CANCER 637, 640 (2012)
34. Myriad, Myriad Expands Financial Assistance Program toUnderinsured Patients,GENOMEWEBDAILYNEWS Jul. 15, 2013, http://www.genomeweb.com/clinical-genomics/myriad-expands-financial-assistance-programunderinsured-patients (accessedMarch 3, 2015)
35. Jeanne Erdmann, Is Your State Legislature Waiting for You to Get Cancer? SLATEMEDICAL EXAMINER Dec. 25, 2013
36. Jennifer K. Litton et al., Earlier Age of Onset of BRCA Mutation-Related Cancers in Subsequent Generations, 118 CANCER 321, 323 (2012)
37. American Cancer Society, Paying for Breast Cancer Screening, http://www.cancer.org/cancer/breastcancer/ moreinformation/breastcancerearlydetection/breast-cancer-early-detection-paying-for-br-ca-screening (accessed March 3, 2015)
38. Henry M. Kuerer et al., Current National Health Insurance Coverage Policies for Breast and Ovarian Cancer Prophylactic Surgery, 7 ANNALS SURGICAL ONCOLOGY 325, 327-29 (2000)
39. Kaiser Family Foundation, Preventive Services Covered by Private Health Plans under the Affordable Care Act, (2011), http://kaiserfamilyfoundation.files.wordpress.com/2013/01/8219.pdf (accessedMarch 3, 2015)
40. U.S. Preventive Services Task Force, Procedure Manual (2011), http://www.uspreventiveservicestaskforce. org/uspstf08/methods/procmanual.htm (accessedMarch 3, 2015)
41. U.S. Preventive Services Task Force, Grade Definitions, http://www.uspreventiveservicestaskforce.org/ uspstf/grades.htm (accessedMarch 3, 2015)
42. The Kaiser Family Foundation and Health Research and Educational Trust, Employer Health Benefits: 2014 Annual Survey, 2014, http://kff.org/report-section/ehbs-2014-summary-of-findings/ (accessed March 3, 2015)
43. AARP Public Policy Institute, Improvements to Medicare's Preventive Services Under Health Reform, 2010, http://assets.aarp.org/rgcenter/ppi/health-care/fs180-preventive.pdf (accessedMarch 3, 2015)
44. Centers for Medicare and Medicaid Services, Preventive & Screening Services, http://www.medicare.gov/ coverage/preventive-and-screening-services.html (accessedMarch 3, 2015)
45. Ned Calonge et al., Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement, 149 ANNALS INT. MED. 627 (2008)
46. Karen Pollitz et al., Coverage of Colonoscopies under the Affordable Care Act's Prevention Benefit, KAISER FAMILY FOUNDATION, AMERICAN CANCER SOCIETY, AND THE NATIONAL COLORECTAL CANCER ROUNDTABLE, Aug. 31, 2012
47. U.S. Department of Labor, FAQs About Affordable Care Act Implementation Part XII, http://www.dol.gov/ ebsa/faqs/faq-aca12.html#6 (accessed March 3, 2015)
48. Michelle Andrews, Questions About Colon Screening Coverage Still Vex Consumers, KAISER HEALTH NEWS, http://www.kaiserhealthnews.org/Features/ Insuring-Your-Health/2013/041613-Michelle-Andrews-preventive-colonoscopy-costs.aspx (accessed March 3, 2015)
49. Health Affairs and Robert Wood Johnson Foundation, Health Policy Brief: Essential Health Benefits, 2013, http://healthaffairs.org/healthpolicybriefs/brief-pdfs/healthpolicybrief-91.pdf (accessed March 3, 2015)
50. Jennifer P. Ruger, Fair Enough? Inviting Inequities in State Health Benefits, 366NEW ENG. J.MED. 681, 681-82 (2012)
51. U.S. Preventive Services Task Force (USPSTF), GeneticRisk Assessment andBRCAMutation Testing for Breast and Ovarian Cancer Susceptibility: Recommendation Statement, 143 ANNALS INT. MED. 355 (2005)
52. Virginia A. Moyer, Risk Assessment, GeneticCounseling, andGenetic Testing for BRCA-RelatedCancer in Women: US Preventive Services Task Force Recommendation Statement, 160 ANNALS INT. MED. 271 (2014)
53. Genetics Home Reference, What is a Gene, U.S. NATIONAL LIBRARY OF MEDICINE, 2014, http://ghr.nlm.nih.gov/handbook/basics/gene (accessedMarch 3, 2015)
54. ACMG Board of Directors, Points to Consider in the Clinical Application of Genomic Sequencing, 14 GENET. MED. 759, 759 (2012)
55. Paul Rincon, Science Enters $1,000 Genome Era, BBC, 2014, www.bbc.co.uk/news/science-environment-25751958 (accessedMarch 3, 2015)
56. National HumanGenome Research Institute,TheHumanGenome Project Completion: Frequently Asked Questions, 2010, http://www.genome.gov/11006943 (accessedMarch 3, 2015)
57. Isaac S. Kohane et al., Taxonomizing, Sizing, and Overcoming the Incidentalome, 14 GENET. MED. 399, 400 (2012)
58. Robert C. Green et al., ACMG Recommendations for Reporting of Incidental Findings in Clinical Exome and Genome Sequencing, 15GENET.MED. 565, 569 (2013)
59. GenomeWeb Daily News, Updated ACMG Recommendations to Allow Patient Opt out of Incidental Findings, 2014, http://www.genomeweb.com/clinical-genomics/updated-acmg-recommendations-allow-patientopt-out-incidental-findings (accessedMarch 3, 2015)
60. John Conley, The ACMG Screening Recommendations, GENOM. L. REP., July 30, 2013, http:// www.genomicslawreport.com/index.php/2013/07/30/the-amg-gene-screening-recommendations/ (accessedMarch 3, 2015)
61. Mark A. Rothstein, The Case against Precipitous, Population-Wide, Whole-Genome Sequencing, 40 J.L.MED. & ETHICS 682, 685 (2012)
62. Wylie Burke et al., Recommendations for Returning Genomic Incidental Findings?We Need to Talk!, 15 GENET. MED. 854, 857 (2013)
63. Muin J. Khoury, Why We Can't Wait: A Public Health Approach to Health Disparities in Genomic Medicine, CENTERS FOR DISEASE CONTROL AND PREVENTION: GENOMICS AND HEALTH IMPACT BLOG, June 27, 2013, http://blogs.cdc.gov/genomics/2013/06/27/why-we-cant-wait/ (accessedMarch 3, 2015)
64. Douglas E. Levy et al., Underutilization of BRCA1/2 Testing to Guide Breast Cancer Treatment: Black and Hispanic Women Particularly at Risk, 13 GENET. MED. 349 (2011)
65. Michael J. Hall & Olufunmilayo I. Olopade, Disparities in Genetic Testing: Thinking Outside the BRCA Box, 24 J. CLINICAL ONCOLOGY 2197 (2006)
66. NationalCancer Institute, Cancer Health Disparities, http://www.cancer.gov/cancertopics/factsheet/ disparities/cancer-health-disparities (accessed March 3, 2015)
67. Cancer Action Network, Americian Cancer Society, Cancer Disparities: A Chartbook, 2009, http://action.acscan.org/site/DocServer/ cancer-disparities-chartbook.pdf?docID=15341 (accessedMarch 3, 2015)
68. DAN W. BROCK et al., FROM CHANCE TO CHOICE: GENETICS AND JUSTICE (2001)
69. Amy Gutmann, For and against Equal Access to Health Care, in INSEARCHOFEQUITY (Ronald Bayer, et al. eds., 1983), at 61
70. Roy C. Baron et al., Client-Directed Interventions to Increase Community Access to Breast, Cervical, and Colorectal Cancer Screening: A Systematic Review, 35 AM. J. PREVENTIVEMED. S56, S61-63 (2008)
71. USPSTF, USPSTF A-Z Topic Guide, http://www.uspreventiveservicestaskforce.org/uspstopics.htm (accessedMarch 3, 2015)
72. Susan A. Berry et al., Insurance Coverage of Medical Foods for Treatment of Inherited Metabolic Disorders, 15 GENET. MED. 978 (2013)
73. Centers forMedicare and Medicaid Services, Additional Information on Proposed State EssentialHealth Benefits Benchmark Plans, http://www.cms.gov/CCIIO/Resources/Data-Resources/ehb.html (accessed March 3, 2015)
74. Jeffrey J. Stoddard & PhilipM. Farrell, State-to-State Variations in Newborn Screenings Policies, 151 ARCHIVES PEDIATRIC & ADOLESCENTMED. 561, 562 (1997)
75. SusanM.Wolf et al., Managing Incidental Findings and Research Results in Genomic Research Involving Biobanks and Archived Data Sets, 14GENET. MED. 361 (2012)
76. Richard R. Fabsitz et al., Ethical and Practical Guidelines for Reporting Genetic Research Results to Study ParticipantsUpdated Guidelines from a National Heart, Lung, and Blood InstituteWorking Group, 3 CIRCULATION CARDIOVASCULAR GENET. 574 (2010)